Filitra-20 is a medication used for the treatment of erectile dysfunction in men. It is classified as a PDE5 inhibitor, which means that it works by inhibiting the enzyme PDE5, responsible for breaking down cyclic guanosine monophosphate (cGMP). By inhibiting PDE5, Filitra-20 increases the levels of cGMP in the body, leading to smooth muscle relaxation and increased blood flow to the penis, resulting in an erection.
One of the main characteristics of Filitra-20 is its active half-life, which is approximately 5-7 hours. This means that the medication remains active in the body for a shorter period compared to other medications used for erectile dysfunction. The recommended dosage for men is 10-20 mg per day.
Filitra-20 does not cause acne, but it is possible to have water retention in the body. However, it does not cause heartburn or acid reflux (HBR). Moreover, Filitra-20 does not cause hepatotoxicity or aromatization.
Filitra-20 is manufactured by Fortune Health Care and is available in the form of 10 pills, each containing 20 mg of the active substance vardenafil. It is important to note that Filitra-20 should only be taken under the supervision of a healthcare professional, and should not be used with other medications that contain nitrates, as this can cause a dangerous drop in blood pressure.
Overall, Filitra-20 is a safe and effective medication for the treatment of erectile dysfunction in men. However, it is important to discuss with a healthcare professional any potential side effects or interactions with other medications before starting the treatment.
Chemical name: 1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine
Anabolic activity index: not a steroid
Androgenic activity index: not a steroid